Daniel D. Burgess

Insider Reports History

Entity
Individual
Location
C/O Hollis Eden Pharmaceuticals, 4435 Eastgate Mall Ste.400, San Diego, CA
Signature
/s/ Shane Ward, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Daniel D. Burgess:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Nabriva Therapeutics plc Director Ordinary Shares 10.4K $15.6K $1.50 Aug 2, 2022 Direct
Arbutus Biopharma Corp Director Stock Option (Right to Buy) 67K May 23, 2024 Direct
Cidara Therapeutics, Inc. Director Stock Option (right to buy) 20.5K Dec 17, 2024 Direct

Insider Reports Filed by Daniel D. Burgess

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CDTX Cidara Therapeutics, Inc. Dec 17, 2024 1 $0 4 Dec 19, 2024 Director
CDTX Cidara Therapeutics, Inc. Jul 18, 2024 1 $0 4 Jul 19, 2024 Director
ABUS Arbutus Biopharma Corp May 23, 2024 1 $0 4 May 24, 2024 Director
CDTX Cidara Therapeutics, Inc. Jun 22, 2023 1 $0 4 Jun 23, 2023 Director
ABUS Arbutus Biopharma Corp May 24, 2023 1 $0 4 May 26, 2023 Director
NBRV Nabriva Therapeutics plc Aug 2, 2022 1 -$2.16K 4 Aug 4, 2022 Director
CDTX Cidara Therapeutics, Inc. Jun 22, 2022 1 $0 4 Jun 24, 2022 Director
ABUS Arbutus Biopharma Corp May 25, 2022 1 $0 4 May 26, 2022 Director
NBRV Nabriva Therapeutics plc Aug 2, 2021 1 -$1.35K 4 Aug 4, 2021 Director
NBRV Nabriva Therapeutics plc Jul 28, 2021 2 $0 4 Jul 30, 2021 Director
CDTX Cidara Therapeutics, Inc. Jun 23, 2021 1 $0 4 Jun 24, 2021 Director
ABUS Arbutus Biopharma Corp Jun 3, 2021 1 $0 4 Jun 7, 2021 Director